Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
- $900,000
- Not stated
- Jul 11, 2025
Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.
Or read the full text and all 4 standing review criteria here, free with an account. Create free account
Summary
The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions…
Related announcements
The full announcement, free with an account
- The full announcement text, not just the first two sentences
- All 4 standing review criteria Food and Drug Administration applies to this kind of proposal (its standard framework, not criteria written for this announcement)
On Plus, $39 a month
- The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
- Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
- A Reviewer Scorecard of your draft against these criteria
More from Food and Drug Administration
Minor Use Minor Species Development of Drugs (R01)
$250k
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
$300k
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
$200k
Laboratory Flexible Funding Model (LFFM)
$1.5M